Innoviva (INVA) Non-Current Debt (2010 - 2026)

Innoviva (INVA) posted Non-Current Debt of $258.1 million for Q1 2026, little changed on a QoQ basis from $257.7 million in Q4 2025, and up 0.56% year-over-year from $256.7 million in Q1 2025.

Innoviva (INVA) Non-Current Debt (2010 - 2026) Analysis & Trends

Innoviva's Non-Current Debt history runs 14 years deep, the most recent figure standing at $258.1 million for Q1 2026.

  • Quarterly Non-Current Debt rose 0.56% year-over-year to $258.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $258.1 million (up 0.56% YoY) and the FY2025 annual result came in at $257.7 million, up 0.55% from the prior year.
  • Non-Current Debt was $258.1 million for Q1 2026 at Innoviva, roughly flat from $257.7 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $447.3 million in Q2 2024 and bottomed at $256.0 million in Q3 2024.
  • A 5-year average of $357.5 million and a median of $443.7 million in 2022 frame the typical range for Non-Current Debt.
  • Annual changes were most pronounced in 2022 — Non-Current Debt rose 13.1% — and 2024, when it sank 42.57%.
  • Innoviva's Non-Current Debt stood at $444.2 million in 2022, then increased by 0.46% to $446.2 million in 2023, then slumped by 42.56% to $256.3 million in 2024, then gained by 0.55% to $257.7 million in 2025, then climbed by 0.14% to $258.1 million in 2026.
  • Business Quant data shows INVA's Non-Current Debt at $258.1 million in Q1 2026, $257.7 million in Q4 2025, and $257.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 105.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 842.92 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 258.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 258.10 Mn
Dec 31, 2025 257.73 Mn
Sep 30, 2025 257.38 Mn
Jun 30, 2025 257.02 Mn
Mar 31, 2025 256.67 Mn
Dec 31, 2024 256.32 Mn
Sep 30, 2024 255.97 Mn
Jun 30, 2024 447.28 Mn
Mar 31, 2024 446.76 Mn
Dec 31, 2023 446.23 Mn
Sep 30, 2023 445.72 Mn
Jun 30, 2023 445.20 Mn
Mar 31, 2023 444.69 Mn
Dec 31, 2022 444.18 Mn
Sep 30, 2022 443.68 Mn
Dec 31, 2021 394.65 Mn
Sep 30, 2021 392.30 Mn
Jun 30, 2021 389.99 Mn
Mar 31, 2021 387.73 Mn
Dec 31, 2020 385.52 Mn